UniProt ID | INT11_HUMAN | |
---|---|---|
UniProt AC | Q5TA45 | |
Protein Name | Integrator complex subunit 11 | |
Gene Name | INTS11 {ECO:0000312|HGNC:HGNC:26052} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 600 | |
Subcellular Localization | Nucleus . Cytoplasm . | |
Protein Description | Catalytic component of the Integrator (INT) complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A) and is recruited to the U1 and U2 snRNAs genes. Mediates the snRNAs 3' cleavage. Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the INT complex. [PubMed: 23904267] | |
Protein Sequence | MPEIRVTPLGAGQDVGRSCILVSIAGKNVMLDCGMHMGFNDDRRFPDFSYITQNGRLTDFLDCVIISHFHLDHCGALPYFSEMVGYDGPIYMTHPTQAICPILLEDYRKIAVDKKGEANFFTSQMIKDCMKKVVAVHLHQTVQVDDELEIKAYYAGHVLGAAMFQIKVGSESVVYTGDYNMTPDRHLGAAWIDKCRPNLLITESTYATTIRDSKRCRERDFLKKVHETVERGGKVLIPVFALGRAQELCILLETFWERMNLKVPIYFSTGLTEKANHYYKLFIPWTNQKIRKTFVQRNMFEFKHIKAFDRAFADNPGPMVVFATPGMLHAGQSLQIFRKWAGNEKNMVIMPGYCVQGTVGHKILSGQRKLEMEGRQVLEVKMQVEYMSFSAHADAKGIMQLVGQAEPESVLLVHGEAKKMEFLKQKIEQELRVNCYMPANGETVTLPTSPSIPVGISLGLLKREMAQGLLPEAKKPRLLHGTLIMKDSNFRLVSSEQALKELGLAEHQLRFTCRVHLHDTRKEQETALRVYSHLKSVLKDHCVQHLPDGSVTVESVLLQAAAPSEDPGTKVLLVSWTYQDEELGSFLTSLLKKGLPQAPS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Phosphorylation | AGQDVGRSCILVSIA CCCCCCCCEEEEEEC | 10.28 | 25332170 | |
115 | Ubiquitination | RKIAVDKKGEANFFT HHHCCCCCCCCCCCC | 58.48 | 21906983 | |
115 (in isoform 3) | Ubiquitination | - | 58.48 | 21890473 | |
115 (in isoform 1) | Ubiquitination | - | 58.48 | 21890473 | |
115 | Sumoylation | RKIAVDKKGEANFFT HHHCCCCCCCCCCCC | 58.48 | - | |
115 | Sumoylation | RKIAVDKKGEANFFT HHHCCCCCCCCCCCC | 58.48 | - | |
127 | Ubiquitination | FFTSQMIKDCMKKVV CCCHHHHHHHHHHHE | 39.26 | - | |
133 (in isoform 2) | Ubiquitination | - | 2.52 | - | |
153 | Phosphorylation | DELEIKAYYAGHVLG CCEEEEEEEHHHHHE | 6.72 | 30576142 | |
161 (in isoform 2) | Ubiquitination | - | 7.50 | 21890473 | |
172 | Phosphorylation | QIKVGSESVVYTGDY EEEECCEEEEEECCC | 20.69 | 30576142 | |
175 | Phosphorylation | VGSESVVYTGDYNMT ECCEEEEEECCCCCC | 11.66 | 30576142 | |
179 (in isoform 2) | Ubiquitination | - | 14.26 | 21890473 | |
188 (in isoform 2) | Ubiquitination | - | 13.71 | 21890473 | |
194 | Ubiquitination | LGAAWIDKCRPNLLI CCHHHHHHCCCCEEE | 24.02 | - | |
206 | Phosphorylation | LLITESTYATTIRDS EEEEECCEECCCCCC | 15.95 | - | |
224 | Ubiquitination | RERDFLKKVHETVER HHHHHHHHHHHHHHC | 51.47 | - | |
234 | Ubiquitination | ETVERGGKVLIPVFA HHHHCCCEEEEEEEE | 36.37 | - | |
240 (in isoform 3) | Ubiquitination | - | 3.79 | 21890473 | |
258 (in isoform 3) | Ubiquitination | - | 15.19 | 21890473 | |
262 (in isoform 1) | Ubiquitination | - | 40.75 | 21890473 | |
262 | Ubiquitination | FWERMNLKVPIYFST HHHHCCCCCCEEEEC | 40.75 | 21906983 | |
266 | Phosphorylation | MNLKVPIYFSTGLTE CCCCCCEEEECCCHH | 5.84 | - | |
267 (in isoform 3) | Ubiquitination | - | 5.66 | 21890473 | |
274 | Ubiquitination | FSTGLTEKANHYYKL EECCCHHHHCEEEEE | 49.61 | - | |
280 | Ubiquitination | EKANHYYKLFIPWTN HHHCEEEEEEEECCC | 29.74 | 21890473 | |
280 | Ubiquitination | EKANHYYKLFIPWTN HHHCEEEEEEEECCC | 29.74 | 21890473 | |
280 | Ubiquitination | EKANHYYKLFIPWTN HHHCEEEEEEEECCC | 29.74 | 21890473 | |
280 (in isoform 1) | Ubiquitination | - | 29.74 | 21890473 | |
280 | Ubiquitination | EKANHYYKLFIPWTN HHHCEEEEEEEECCC | 29.74 | 21890473 | |
289 | Ubiquitination | FIPWTNQKIRKTFVQ EEECCCHHHHHHHHH | 46.69 | 21890473 | |
289 | Ubiquitination | FIPWTNQKIRKTFVQ EEECCCHHHHHHHHH | 46.69 | 21890473 | |
289 (in isoform 1) | Ubiquitination | - | 46.69 | 21890473 | |
289 | Ubiquitination | FIPWTNQKIRKTFVQ EEECCCHHHHHHHHH | 46.69 | 21890473 | |
289 | Ubiquitination | FIPWTNQKIRKTFVQ EEECCCHHHHHHHHH | 46.69 | 21890473 | |
303 | Ubiquitination | QRNMFEFKHIKAFDR HHCCCCCCCHHHHHH | 36.90 | - | |
317 (in isoform 2) | Ubiquitination | - | 29.23 | 21890473 | |
345 | Ubiquitination | RKWAGNEKNMVIMPG HHHCCCCCCEEEECC | 55.10 | - | |
362 | Ubiquitination | VQGTVGHKILSGQRK EECCHHHHHHCCCEE | 39.14 | - | |
385 (in isoform 2) | Ubiquitination | - | 20.73 | 21890473 | |
396 (in isoform 3) | Ubiquitination | - | 49.90 | 21890473 | |
399 (in isoform 2) | Ubiquitination | - | 3.25 | 21890473 | |
418 (in isoform 1) | Ubiquitination | - | 48.64 | 21890473 | |
418 | Ubiquitination | LLVHGEAKKMEFLKQ EEEECCHHHHHHHHH | 48.64 | 21906983 | |
426 | Ubiquitination | KMEFLKQKIEQELRV HHHHHHHHHHHHHCC | 46.77 | - | |
445 | Acetylation | PANGETVTLPTSPSI CCCCCEEECCCCCCC | 34.14 | 19608861 | |
445 | Phosphorylation | PANGETVTLPTSPSI CCCCCEEECCCCCCC | 34.14 | 28655764 | |
451 | Phosphorylation | VTLPTSPSIPVGISL EECCCCCCCCCCHHH | 39.01 | 28655764 | |
464 (in isoform 3) | Ubiquitination | - | 36.96 | 21890473 | |
474 | Acetylation | QGLLPEAKKPRLLHG CCCCCCCCCCCEEEE | 62.74 | 19608861 | |
478 (in isoform 3) | Ubiquitination | - | 5.85 | 21890473 | |
480 | Acetylation | AKKPRLLHGTLIMKD CCCCCEEEEEEEEEC | 31.61 | 19608861 | |
482 | Phosphorylation | KPRLLHGTLIMKDSN CCCEEEEEEEEECCC | 11.45 | 20068231 | |
486 (in isoform 1) | Ubiquitination | - | 51.52 | 21890473 | |
486 | Ubiquitination | LHGTLIMKDSNFRLV EEEEEEEECCCEEEE | 51.52 | 21890473 | |
486 | Ubiquitination | LHGTLIMKDSNFRLV EEEEEEEECCCEEEE | 51.52 | 21890473 | |
486 | Ubiquitination | LHGTLIMKDSNFRLV EEEEEEEECCCEEEE | 51.52 | 21890473 | |
486 | Ubiquitination | LHGTLIMKDSNFRLV EEEEEEEECCCEEEE | 51.52 | 21890473 | |
500 | Ubiquitination | VSSEQALKELGLAEH ECHHHHHHHHCCCHH | 54.64 | 21890473 | |
500 (in isoform 1) | Ubiquitination | - | 54.64 | 21890473 | |
500 | Ubiquitination | VSSEQALKELGLAEH ECHHHHHHHHCCCHH | 54.64 | 21890473 | |
500 | Ubiquitination | VSSEQALKELGLAEH ECHHHHHHHHCCCHH | 54.64 | 21890473 | |
500 | Ubiquitination | VSSEQALKELGLAEH ECHHHHHHHHCCCHH | 54.64 | 21890473 | |
532 | Phosphorylation | ETALRVYSHLKSVLK HHHHHHHHHHHHHHH | 21.34 | 30622161 | |
535 | Acetylation | LRVYSHLKSVLKDHC HHHHHHHHHHHHHHH | 32.85 | 25953088 | |
535 | Ubiquitination | LRVYSHLKSVLKDHC HHHHHHHHHHHHHHH | 32.85 | - | |
539 | Ubiquitination | SHLKSVLKDHCVQHL HHHHHHHHHHHHHCC | 43.18 | - | |
589 | Phosphorylation | ELGSFLTSLLKKGLP HHHHHHHHHHHCCCC | 33.57 | 24719451 | |
593 | Ubiquitination | FLTSLLKKGLPQAPS HHHHHHHCCCCCCCC | 66.70 | - | |
593 | Acetylation | FLTSLLKKGLPQAPS HHHHHHHCCCCCCCC | 66.70 | 25825284 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of INT11_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of INT11_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of INT11_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RPB1_HUMAN | POLR2A | physical | 16239144 | |
INT2_HUMAN | INTS2 | physical | 16239144 | |
INT9_HUMAN | INTS9 | physical | 16239144 | |
DSE_HUMAN | DSE | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...